← Back to Clinical Trials
Recruiting NCT07088536

NCT07088536 Occupational Situation and Return to Work of Urological Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07088536
Status Recruiting
Phase
Sponsor Jagiellonian University
Condition Bladder Cancer
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2025-07-21
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patients

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2025-07-21 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will examine the work status of all adult patients admitted over a 6-month period to the University Hospital in Kraków, Poland, for treatment of urological diseases. All admitted patients will be surveyed about their job situation. Patients who are occupationally active and undergoing major oncological surgeries (such as radical cystectomy, prostatectomy, or nephrectomy) or procedures for urinary tract stones will also complete a quality-of-life questionnaire and be followed up by phone at 3 and 6 months. The goal is to learn how treatment affects patients' ability to return to work and their well-being, to help guide support and rehabilitation strategies.

Eligibility Criteria

Inclusion Criteria: 1. Adult patients (≥18 years) admitted to the Department of Urology and Oncological Urology, University Hospital in Kraków, during the 6-month study period. 2. For the prospective follow-up cohort: 1. Occupationally active (employed) at baseline. 2. Undergoing major uro-oncological surgery (e.g., radical cystectomy, radical prostatectomy, nephrectomy) or a procedure for urinary tract stones (e.g., ureterorenoscopy, percutaneous nephrolithotripsy). 3. Able and willing to provide written informed consent. Exclusion Criteria: 1. Patients unwilling or unable to provide informed consent. 2. Patients who are unemployed or retired at baseline (excluded from the prospective follow-up cohort but included in the baseline cross-sectional survey). 3. Patients not undergoing major uro-oncological surgery or urinary tract stone procedures (for the prospective follow-up cohort).

Contact & Investigator

Central Contact

Anna K. Czech, M.D., Ph.D.

✉ aka.czech@uj.edu.pl

📞 +48124002500

Frequently Asked Questions

Who can join the NCT07088536 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07088536 currently recruiting?

Yes, NCT07088536 is actively recruiting participants. Contact the research team at aka.czech@uj.edu.pl for enrollment information.

Where is the NCT07088536 trial being conducted?

This trial is being conducted at Krakow, Poland.

Who is sponsoring the NCT07088536 clinical trial?

NCT07088536 is sponsored by Jagiellonian University. The trial plans to enroll 2,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology